Analysis Shows No Benefit for Cytoreductive Nephrectomy Analysis Shows No Benefit for Cytoreductive Nephrectomy
For patients with metastatic clear cell renal cell carcinoma, removing the kidney and its primary tumor is not associated with improved overall survival, a new analysis concludes.Medscape Medical News
Source: Medscape Medical News Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer & Oncology | Carcinoma | Health | Hematology | Kidney Cancer | Nephrectomy | Renal Cell Carcinoma | Urology & Nephrology